Back to Temasek Holdings (Private) Ltd

DNLI
Showing 8 of 30 quarters

Position history for Temasek Holdings (Private) Ltd's holdings in DENALI THERAPEUTICS INC

Temasek Holdings (Private) Ltd holds 7M shares of DNLI (DENALI THERAPEUTICS INC), worth $134.6M as of 2026-Q1. DNLI represents 0.4% of Temasek Holdings (Private) Ltd's portfolio.

Current Value

$134.6M

Current Shares

7M

Total Value Change

+$2.1M

Total Shares Change

+1.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Unchanged
7M
0.0%
$134.6M0.4%$20.02
0
2025-Q4
Increased
7M
+30.9%
$115.8M0.4%$16.41
46
2025-Q3
Unchanged
5.4M
0.0%
$77.8M0.3%$14.52
0
2025-Q2
Unchanged
5.4M
0.0%
$74.9M0.3%$14.10
0
2025-Q1
Unchanged
5.4M
0.0%
$72.8M0.3%$14.78
0
2024-Q4
Unchanged
5.4M
0.0%
$109.2M0.4%$20.24
0
2024-Q3
Decreased
5.4M
-6.1%
$156M0.6%$29.43
0
2024-Q2
Unchanged
5.7M
0.0%
$132.5M0.6%$23.22
0

Other major holders of DNLI: BAILLIE GIFFORD & CO

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used